☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Vasa Therapeutics
Vasa Therapeutics Reports the Initiation of the P-I Trial Evaluating VS-041 for the Treatment of HFpEF
September 4, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.